Enfermedad carotídea Dr. Costantino Pena

More articles by this author

Conferencia del Dr. Qureshi

Conferencia del Dr. Qureshi

Stent Thrombosis: a note of caution Dr. Conrad Simpfendorfer

Stent Thrombosis: a note of caution Dr. Conrad Simpfendorfer

Dosis de clopidogrel: ¿300 mg, 600 mg, 900 mg, o más? Dr. Neil Kleiman

Dosis de clopidogrel: ¿300 mg, 600 mg, 900 mg, o más? Dr. Neil Kleiman

Angioplastia para Oclusión Total Crónica Dr. Shigeru Saito

Angioplastia para Oclusión Total Crónica Dr. Shigeru Saito

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Long-Term Predictors of Valve Deterioration After TAVI

Transcatheter aortic valve implantation (TAVI) has become an innovative technology for the treatment of patients with severe aortic valve stenosis. Initially implemented in elderly...

Coronary access after TAVI with fourth- and fifth-generation Evolut valves: the EPROMPT-CA study

The expansion of transcatheter aortic valve implantation (TAVI) toward younger and lower-risk patients has increased the relevance of post-procedural coronary access. In this context,...

Morpheus Global Registry: Safety and efficacy of the long tapered BioMime™ Morph stent in complex coronary lesions

Percutaneous coronary intervention in long coronary lesions continues to represent a technical and clinical challenge, in which the use of conventional cylindrical stents may...